ORENCIA - 0003-2188-82 - (abatacept)

Alphabetical Index


Drug Information of ORENCIA

Product NDC: 0003-2188
Proprietary Name: ORENCIA
Non Proprietary Name: abatacept
Active Ingredient(s): 125    mg/mL & nbsp;   abatacept
Administration Route(s): SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of ORENCIA

Product NDC: 0003-2188
Labeler Name: E.R. Squibb & Sons, L.L.C.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA125118
Marketing Category: BLA
Start Marketing Date: 20110729

Package Information of ORENCIA

Package NDC: 0003-2188-82
Package Description: 1 SYRINGE, GLASS in 1 CARTON (0003-2188-82) > 1 mL in 1 SYRINGE, GLASS

NDC Information of ORENCIA

NDC Code 0003-2188-82
Proprietary Name ORENCIA
Package Description 1 SYRINGE, GLASS in 1 CARTON (0003-2188-82) > 1 mL in 1 SYRINGE, GLASS
Product NDC 0003-2188
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name abatacept
Dosage Form Name INJECTION, SOLUTION
Route Name SUBCUTANEOUS
Start Marketing Date 20110729
Marketing Category Name BLA
Labeler Name E.R. Squibb & Sons, L.L.C.
Substance Name ABATACEPT
Strength Number 125
Strength Unit mg/mL
Pharmaceutical Classes Decreased Cytokine Activity [PE],Selective T Cell Costimulation Modulator [EPC],Recombinant Fusion Proteins [Chemical/Ingredient]

Complete Information of ORENCIA


General Information